477 related articles for article (PubMed ID: 6689702)
1. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
Hubbard JL; Scheithauer BW; Abboud CF; Laws ER
J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
[TBL] [Abstract][Full Text] [Related]
3. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
Esiri MM; Bevan JS; Burke CW; Adams CB
J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
[TBL] [Abstract][Full Text] [Related]
4. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine therapy as pre-operative adjunct of non-functional pituitary macroadenomas.
Zárate A; Morán C; Klériga E; Loyo M; González-Angulo A; Aquilar-Parada E
Acta Endocrinol (Copenh); 1985 Apr; 108(4):445-50. PubMed ID: 3993311
[TBL] [Abstract][Full Text] [Related]
6. Rapid regression of pituitary prolactinomas during bromocriptine treatment.
Thorner MO; Martin WH; Rogol AD; Morris JL; Perryman RL; Conway BP; Howards SS; Wolfman MG; MacLeod RM
J Clin Endocrinol Metab; 1980 Sep; 51(3):438-45. PubMed ID: 6773972
[TBL] [Abstract][Full Text] [Related]
7. [Pathological changes of prolactinomas treated with bromocriptine].
Teramoto A; Takakura K; Fukushima T; Osamura Y
No Shinkei Geka; 1982 Jun; 10(6):619-27. PubMed ID: 7121729
[TBL] [Abstract][Full Text] [Related]
8. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
[TBL] [Abstract][Full Text] [Related]
9. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
Jones TH; Figueroa CD; Smith CM; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
[TBL] [Abstract][Full Text] [Related]
10. [Bromocriptine for prolactin-secreting macroadenomas of the pituitary].
Landman L; Spindel A; Tal Y; Bar-Meir A; Sharf M; Dickstein G
Harefuah; 1987 Oct; 113(7-8):156-9. PubMed ID: 3428740
[No Abstract] [Full Text] [Related]
11. Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors.
Laws ER; Fode NC; Randall RV; Abboud CF; Coulam CB
J Neurosurg; 1983 May; 58(5):685-8. PubMed ID: 6834116
[TBL] [Abstract][Full Text] [Related]
12. Management of prolactinomas associated with very high serum prolactin levels.
Barrow DL; Mizuno J; Tindall GT
J Neurosurg; 1988 Apr; 68(4):554-8. PubMed ID: 3351583
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study.
Bassetti M; Spada A; Pezzo G; Giannattasio G
J Clin Endocrinol Metab; 1984 Feb; 58(2):268-73. PubMed ID: 6693536
[TBL] [Abstract][Full Text] [Related]
14. Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis.
Mori H; Mori S; Saitoh Y; Arita N; Aono T; Uozumi T; Mogami H; Matsumoto K
Cancer; 1985 Jul; 56(2):230-8. PubMed ID: 4005795
[TBL] [Abstract][Full Text] [Related]
15. Perivascular fibrosis in prolactinomas: is it increased by bromocriptine?
Landolt AM; Osterwalder V
J Clin Endocrinol Metab; 1984 Jun; 58(6):1179-83. PubMed ID: 6725514
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
Molitch ME; Elton RL; Blackwell RE; Caldwell B; Chang RJ; Jaffe R; Joplin G; Robbins RJ; Tyson J; Thorner MO
J Clin Endocrinol Metab; 1985 Apr; 60(4):698-705. PubMed ID: 3882737
[TBL] [Abstract][Full Text] [Related]
17. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
[TBL] [Abstract][Full Text] [Related]
18. [Histological changes and operative findings of pituitary adenomas after bromocriptine treatment].
Takahashi T; Kuwayama A; Katoh T; Kageyama N
Nihon Naibunpi Gakkai Zasshi; 1986 Dec; 62(12):1336-51. PubMed ID: 3817228
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
Schettini G; Lombardi G; Merola B; Miletto P; Fariello C; Cirillo S; Fusco R; Lancranjan I
J Endocrinol Invest; 1988 Jan; 11(1):47-51. PubMed ID: 3361075
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
Montini M; Pagani G; Gianola D; Pagani MD; Salmoiraghi M; Ferrari L; Lancranjan I
J Clin Endocrinol Metab; 1986 Jul; 63(1):266-8. PubMed ID: 3711262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
